Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Jan/21/2022 16 1
Tenofovir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021 4 3
Emtricitabine Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021 2 2
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Tipiracil  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021 2 0
MVA/S Potential treatment - pre-clinical evidence Experimental Vaccine Feb/03/2021 1 0
Excel (.xslx) CSV (.csv)